Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in PNTM Infection
NCT01853540Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in Nontuberculous Mycobacterial Lung Disease (NTM-LD), sponsored by National Institute of Allergy and Infectious Diseases. Started Jan 2013; status: completed.
02
Drugs
sildenafil
03
Conditions
Nontuberculous Mycobacterial Lung Disease (NTM-LD)
Beyond the preview
Go deeper on NCT01853540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01853540.